Castle Biosciences Inc (CSTL) insider trading

Every open-market stock purchase and sale by Castle Biosciences Inc executives, directors, large shareholders and members of Congress, from SEC Form 4 filings. Sector: Other.

Insider activity at a glance

  • Insiders sold $10M over the last 12 months (38 sales). No open-market buys.
  • Last insider buy: Ellen Goldberg (Director), $43.2K, 3 years ago.

Last 12 months: insiders bought $0 (0 buys) and sold $10M (38 sales). Last close $21.01 on Jun 4, 2026.

Recent CSTL insider trades

DateInsiderTradeValue
Jun 16, 2026Kristen M Oelschlager (COO)Sold$178K
Jun 15, 2026Derek J Maetzold (Officer)Sold$28K
Jun 15, 2026Derek J Maetzold (Officer)Sold$23.8K
Jun 15, 2026Derek J Maetzold (Officer)Sold$11.4K
Jun 15, 2026Derek J Maetzold (Officer)Sold$5.7K
Jun 15, 2026Derek J Maetzold (Officer)Bought (not open market)—
Jun 1, 2026Derek J Maetzold (Officer)Sold$130K
Jun 1, 2026Derek J Maetzold (Officer)Sold$28.3K
Jun 1, 2026Derek J Maetzold (Officer)Sold$24K
Jun 1, 2026Derek J Maetzold (Officer)Sold$5.8K
Jun 1, 2026Derek J Maetzold (Officer)Bought (not open market)—
Jun 1, 2026Derek J Maetzold (Officer)Bought (not open market)—
May 28, 2026Tiffany Olson (Director)Bought (not open market)—
May 28, 2026Daniel Bradbury (Director)Bought (not open market)—
May 28, 2026Kim Caple (Director)Bought (not open market)—
May 28, 2026Ellen Goldberg (Director)Bought (not open market)—
May 28, 2026G Bradley Cole (Director)Bought (not open market)—
May 28, 2026Miles Harrison (Director)Bought (not open market)—
May 28, 2026Rodney Cotton (Director)Bought (not open market)—
May 22, 2026Miles Harrison (Director)Bought (not open market)—
May 22, 2026G Bradley Cole (Director)Bought (not open market)—
May 22, 2026Ellen Goldberg (Director)Bought (not open market)—
May 22, 2026Daniel Bradbury (Director)Bought (not open market)—
May 22, 2026Tiffany Olson (Director)Bought (not open market)—
May 22, 2026Rodney Cotton (Director)Bought (not open market)—

Who's trading CSTL

Get free alerts when an insider at Castle Biosciences Inc files a new trade →